Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Swords

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Hematology (Amsterdam, Netherlands)|June 15, 2007
Troxacitabine in acute leukemiaR Swords, F Giles
Leukemia|May 23, 2012
Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemiaR Swords, C Freeman, F Giles
Leukemia|May 29, 2009
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaF J Giles, M O'Dwyer, R Swords
Leukemia|June 4, 2014
Novel myelofibrosis treatment strategies: potential partners for combination therapiesB L Stein, R Swords, A Hochhaus, et al.
Annals of Hematology|March 29, 2006
Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiencyP T Murphy, J P Quinn, D O'Donghaile, et al.
Clinical and Laboratory Haematology|January 25, 2006
Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximabR Swords, A Nolan, M Fay, et al.
Clinical and Laboratory Haematology|September 24, 2005
CML clonal evolution with resistance to single agent imatinib therapyR Swords, J Quinn, M Fay, et al.
British Journal of Cancer|April 30, 2009
Targeting HSP90 for cancer therapyD Mahalingam, R Swords, J S Carew, et al.
Leukemia|October 11, 2016
Isocitrate dehydrogenase mutations in myeloid malignanciesB C Medeiros, A T Fathi, C D DiNardo, et al.
Irish Journal of Medical Science|August 13, 2005
Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003P J Hayden, A O'Driscoll, N Gardiner, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hematology (Amsterdam, Netherlands)|June 15, 2007
Troxacitabine in acute leukemiaR Swords, F Giles
Leukemia|May 23, 2012
Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemiaR Swords, C Freeman, F Giles
Leukemia|May 29, 2009
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaF J Giles, M O'Dwyer, R Swords
Leukemia|June 4, 2014
Novel myelofibrosis treatment strategies: potential partners for combination therapiesB L Stein, R Swords, A Hochhaus, et al.
Annals of Hematology|March 29, 2006
Myelodysplastic patients with raised percentage of hypochromic red cells have evidence of functional iron deficiencyP T Murphy, J P Quinn, D O'Donghaile, et al.
Clinical and Laboratory Haematology|January 25, 2006
Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximabR Swords, A Nolan, M Fay, et al.
Clinical and Laboratory Haematology|September 24, 2005
CML clonal evolution with resistance to single agent imatinib therapyR Swords, J Quinn, M Fay, et al.
British Journal of Cancer|April 30, 2009
Targeting HSP90 for cancer therapyD Mahalingam, R Swords, J S Carew, et al.
Leukemia|October 11, 2016
Isocitrate dehydrogenase mutations in myeloid malignanciesB C Medeiros, A T Fathi, C D DiNardo, et al.
Irish Journal of Medical Science|August 13, 2005
Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003P J Hayden, A O'Driscoll, N Gardiner, et al.
Pageof 1